BioCentury
ARTICLE | Financial News

Melinta raises $46M toward venture round

June 11, 2015 1:21 AM UTC

Melinta Therapeutics Inc. (New Haven, Conn.) raised $46 million of a planned $67 million venture round led by new investor Malin Corp. plc (ISE:MLC). Existing investor Vatera Healthcare Partners and additional undisclosed investors also participated. CFO Paul Estrem said the round is Melinta's fourth since it recapitalized in 2012.

Malin contributed $35 million to the round and intends to commit an additional $10 million. Melinta is Malin's first new investment since its IPO in March (see BioCentury Extra, March 20). ...